High strength and high elasticity with excellent bone affinity! Development of bone fixation materials with superior mechanical strength.
Our company is engaged in the development and creation of high-elasticity biodegradable bone fixation materials. To overcome the challenges associated with currently clinically used poly-L-lactic acid (PLLA) bone fixation materials, we are working on the development of bone fixation materials with superior mechanical strength. The technology under research and development uses PLLA as a matrix and incorporates fibers made into stereo-complex crystals, meeting the mechanical performance required in the early stages of treatment. We are developing materials that more closely approximate the strength characteristics of human bone, contributing to the improvement of patients' quality of life with high-strength, high-elasticity, and high bone affinity biodegradable bone fixation materials. 【Features】 - Engaged in the development of bone fixation materials with excellent mechanical strength - Utilizes a new composite made from fibers in stereo-complex crystals, meeting the mechanical performance required in the early stages of treatment - Developing materials that more closely approximate the strength characteristics of human bone - Biodegradable bone fixation materials with high strength, high elasticity, and high bone affinity *For more details, please refer to the PDF document or feel free to contact us.
Inquire About This Product
basic information
For more details, please refer to the PDF document or feel free to contact us.
Price range
Delivery Time
Applications/Examples of results
【Applications】 ■Biodegradable bone fixation materials, etc. *For more details, please refer to the PDF document or feel free to contact us.
catalog（1）
Download All Catalogs
Company information
BMG is a research and development venture company that has been challenging the development of new biomaterial products adapted to trends in the medical field, based on a long-standing strong collaboration with the Kyoto University Institute for Advanced Medical Research. Focusing on the field of medical polymers (macromolecules), we are engaged in two promising growth businesses: the "BioDegmer" business and the new products business, as well as research and development aimed at providing innovative solutions in the medical field. Under the management philosophy of "contributing to the health of people around the world by working on the development of better biomaterial products and providing innovative solutions in the medical field," we support the improvement of technologies in the next generation of regenerative medicine and the healthy well-being of people in three areas.